Conference
April 17-22, 2026
American Association for Cancer Research® (AACR) Annual Meeting 2026
Join us at the AACR Annual Meeting 2026 to learn how Inocras’ cancer whole genome platform is driving innovation in cancer research and clinical solutions. TCGA and Beyond: The Broad Institute and Inocras share new insights from our collaborative efforts to analyze over 8,000 tumor-normal paired whole genome data released by the NCI TCGA initiative. The two organizations will also introduce Cancer Genome Nexus, a next big collaborative initiative aimed at scaling the robust and standardized whole genome framework to larger-scale dataset. See the information on all events and 16 posters to be presented from this effort and download the Cancer Genome Nexus Presentations & Posters Onepager. Download Learn about Inocras’ whole genome portfolio – across clinical assays and research solutions Clinical assays (CAP/CLIA LDT): CancerVision™ Whole Genomic Profiling (WGP) test for therapy selection to maximize cancer insights to support oncologists on patient’s treatment decision making. MRDVision™ Whole genome based, ultrasensitive, tissue informed MRD detection test RareVision™ is a future-proof WGS based genetic test that maximizes diagnostic yield Research Solutions: High quality data generation: WGS, WES, WTS, Methylation, Single Cell, Spatial Transcriptomics Custom bioinformatics and custom assay development Visit us at Inocras booth # 3145 Connect with our team to see how we can support your breakthrough research and the implementation of patient-focused, whole-genome clinical testing at your institution. Schedule a meeting with Inocras team at AACR Join our exhibitor spotlight presentation and posters to learn about our groundbreaking collaboration with Broad Institute